國立虎尾科技大學 |

Algae-Based Biopharmaceuticals

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Algae-Based Biopharmaceuticals/ by Sergio Rosales-Mendoza.
作者:	Rosales-Mendoza, Sergio.
面頁冊數:	X, 166 p. 47 illus., 22 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Plant breeding. -
電子資源:	https://doi.org/10.1007/978-3-319-32232-2
ISBN:	9783319322322

Algae-Based Biopharmaceuticals
Rosales-Mendoza, Sergio.

Algae-Based Biopharmaceuticals[electronic resource] /by Sergio Rosales-Mendoza. - 1st ed. 2016. - X, 166 p. 47 illus., 22 illus. in color.online resource.

The Biopharmaceuticals Field and Algae as Expression Hosts -- Genetic Engineering Approaches for Algae -- Algae-made Vaccines Targeting Human Diseases -- Algae-made Vaccines Targeting Animal Pathogens -- Algae-made Antibodies and Immunotoxins -- Algae-made Cytokines and Growth Factors -- Other Biopharmaceuticals Produced in Algae -- Algae-made Nutraceuticals -- Perspectives for the Algae-made Biopharmaceuticals Field.

This book constitutes a key reference on the use of algae in the BFs production field; providing an updated outlook on the achievements accomplished thus far and transmitting a prospective view for this biotechnological application. This book provides a detailed description of the technology as well as an updated outlook of the strides achieved thus far in the field of algae-based biopharmaceuticals. Algae constitute attractive expression hosts for the production of recombinant proteins with medical applications. Among the features that make them attractive candidates are: low cost, fast growth, wide biosynthetic capacity, and absence of human pathogens; which constitute substantial advantages with respect to bacterial and mammalian systems. First, the features of algae as convenient hosts for the production of BFs are analyzed in terms of production costs, biosynthetic capacity, and safety (Chapter 1). Second, the genetic engineering tools for algae-species are described. Nuclear and chloroplast-based expression approaches are analyzed and compared in terms of biosynthetic advantages, gene expression complexity, and DNA transfer approaches (Chapter 2). In the following sections, chapters 3 to 7, the state of the art on producing distinct types of BFs in algae species is presented. Although this book is mainly focused on BFs, considering that the production of compounds with health-promoting properties are achieved using genetically-engineered algae strains, chapter 8 deals with nutraceuticals. In the ninth chapter, the developments reported thus far are placed in perspective and challenges for the field are discussed. Critical future prospects comprise the following: optimizing large-scale production in bioreactors, implementing glycoengineering approaches, optimizing nuclear expression, exploring new approaches for oral delivery, and implementing regulatory frameworks to accomplish technology transfer and regulatory approval of algae-made BFs.

ISBN: 9783319322322

Standard No.: 10.1007/978-3-319-32232-2doiSubjects--Topical Terms:

568050
Plant breeding.

LC Class. No.: SB123-123.5

Dewey Class. No.: 631.52

Algae-Based Biopharmaceuticals
LDR:03832nam a22004335i 4500 001 974810
003 DE-He213
005 20200705071620.0
007 cr nn 008mamaa
008 201211s2016 gw | s |||| 0|eng d
020 $a 9783319322322 $9 978-3-319-32232-2
024 7 $a 10.1007/978-3-319-32232-2 $2 doi
035 $a 978-3-319-32232-2
050 4 $a SB123-123.5
050 4 $a S494.5.B563
072 7 $a PSTL $2 bicssc
072 7 $a SCI011000 $2 bisacsh
072 7 $a PST $2 thema
072 7 $a TCB $2 thema
082 0 4 $a 631.52 $2 23
082 0 4 $a 660.6 $2 23
100 1 $a Rosales-Mendoza, Sergio. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1108613
245 1 0 $a Algae-Based Biopharmaceuticals $h [electronic resource] / $c by Sergio Rosales-Mendoza.
250 $a 1st ed. 2016.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a X, 166 p. 47 illus., 22 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a The Biopharmaceuticals Field and Algae as Expression Hosts -- Genetic Engineering Approaches for Algae -- Algae-made Vaccines Targeting Human Diseases -- Algae-made Vaccines Targeting Animal Pathogens -- Algae-made Antibodies and Immunotoxins -- Algae-made Cytokines and Growth Factors -- Other Biopharmaceuticals Produced in Algae -- Algae-made Nutraceuticals -- Perspectives for the Algae-made Biopharmaceuticals Field.
520 $a This book constitutes a key reference on the use of algae in the BFs production field; providing an updated outlook on the achievements accomplished thus far and transmitting a prospective view for this biotechnological application. This book provides a detailed description of the technology as well as an updated outlook of the strides achieved thus far in the field of algae-based biopharmaceuticals. Algae constitute attractive expression hosts for the production of recombinant proteins with medical applications. Among the features that make them attractive candidates are: low cost, fast growth, wide biosynthetic capacity, and absence of human pathogens; which constitute substantial advantages with respect to bacterial and mammalian systems. First, the features of algae as convenient hosts for the production of BFs are analyzed in terms of production costs, biosynthetic capacity, and safety (Chapter 1). Second, the genetic engineering tools for algae-species are described. Nuclear and chloroplast-based expression approaches are analyzed and compared in terms of biosynthetic advantages, gene expression complexity, and DNA transfer approaches (Chapter 2). In the following sections, chapters 3 to 7, the state of the art on producing distinct types of BFs in algae species is presented. Although this book is mainly focused on BFs, considering that the production of compounds with health-promoting properties are achieved using genetically-engineered algae strains, chapter 8 deals with nutraceuticals. In the ninth chapter, the developments reported thus far are placed in perspective and challenges for the field are discussed. Critical future prospects comprise the following: optimizing large-scale production in bioreactors, implementing glycoengineering approaches, optimizing nuclear expression, exploring new approaches for oral delivery, and implementing regulatory frameworks to accomplish technology transfer and regulatory approval of algae-made BFs.
650 0 $a Plant breeding. $3 568050
650 0 $a Aquatic ecology . $3 1253656
650 0 $a Pharmaceutical technology. $3 557391
650 0 $a Plant anatomy. $3 905398
650 0 $a Plant development. $3 1253478
650 1 4 $a Plant Breeding/Biotechnology. $3 677715
650 2 4 $a Freshwater & Marine Ecology. $3 676940
650 2 4 $a Pharmaceutical Sciences/Technology. $3 768561
650 2 4 $a Plant Anatomy/Development. $3 668688
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319322308
776 0 8 $i Printed edition: $z 9783319322315
776 0 8 $i Printed edition: $z 9783319812298
856 4 0 $u https://doi.org/10.1007/978-3-319-32232-2
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)